Cargando…
LncRNA SLC16A1‐AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR‐411/MITD1 axis
BACKGROUND: Hepatocellular carcinoma (HCC) is a common malignancy with high morbidity. The current study aimed to explore the molecular mechanism of lncRNA SLC16A1‐AS1 in the tumorigenesis of HCC. MATERIAL AND METHODS: The expression of SLC16A1‐AS1 and miR‐411 was examined in clinical HCC tissues. H...
Autor principal: | Duan, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993651/ https://www.ncbi.nlm.nih.gov/pubmed/35293026 http://dx.doi.org/10.1002/jcla.24344 |
Ejemplares similares
-
LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis
por: Fu, Su-Wei, et al.
Publicado: (2020) -
LncRNA SLC16A1-AS1 Suppresses Cell Proliferation in Cervical Squamous Cell Carcinoma (CSCC) Through the miR-194/SOCS2 Axis
por: Zhang, Huizhen, et al.
Publicado: (2021) -
LncRNA SLC16A1-AS1 is Upregulated in Glioblastoma and Promotes Cancer Cell Proliferation by Regulating miR-149 Methylation
por: Long, Yinbo, et al.
Publicado: (2021) -
MITD1 is recruited to midbodies by ESCRT-III and participates in cytokinesis
por: Lee, Seongju, et al.
Publicado: (2012) -
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)